Delivery Order SPE2DB22D3301-SPE2DB24FZ1RA
Award Date
7/29/24
Potential Completion Date
7/30/24
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Gadavist 1 mmol/ml bulk vials, a medical product used in healthcare applications. The contract has a firm fixed price of $1,242.58 and an ultimate completion date of February 20, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Gadavist 1 mmol/ml bulk vials (30 ml). The order has a ceiling value of $1,711.35 and is a firm fixed price contract with a completion date of July 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of Gadavist 1 mmol/ml bulk vials (30 ml) and has a ceiling value of $1,711.35. The delivery order is part of a larger indefinite delivery contract (IDC) that AmerisourceBergen Drug Corp holds with DLA, which has a potential value of $999,999,999.00 through December 31, 2025....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Gadavist 10 mmol/10 ml vials. The contract has a firm fixed price of $2,194.40 and a completion date of August 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the government to efficiently procure...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gadavist 1 mmol/ml bulk vials, a specialty pharmaceutical product. The contract has a ceiling value of $1,704.90 and a performance period running through March 10, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Gadavist, a pharmaceutical product, with a ceiling value of $1,062.40 and an ultimate completion date of January 21, 2025. The contract is a firm-fixed-price delivery order, which is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of Gadavist, a pharmaceutical product. The contract has a ceiling value of $22,522.21 and an ultimate completion date of September 4, 2024. It is a firm fixed price contract, and there is no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide the Gadavist product to support the medical needs of military treatment facilities and...
This is a $1,704.90 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Gadavist 1 mmol/ml bulk vials, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,239.87, is for the supply of Gadavist 10 MMOL/10 ML vials, with a period of performance through December 14, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,942.00, is for the procurement of Gadavist, a 10 milliliters per vial medical product, with a performance period through January 8, 2024. This contract award is associated with Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop...